Physician

Lawrence Y Ho, M.D.

According to 2025 Medicare claims, Lawrence Ho, M.D. (NPI: 1609078427) practices ophthalmology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Cumberland, PA. This provider's primary affiliated billing organization is PENNSYLVANIA RETINA SPECIALISTS PC (NPI: 1568428126; TIN: 232152842) and primary practice location at 17011-1776.

Ho's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 782 traditional Medicare patients, billed 56,817 HCPCS/CPT codes, and received $2,756,315 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 450 prescription claims across 138 beneficiaries totaling $162,102 in drug costs, led by Vabysmo (Faricimab-Svoa). Open Payments data shows 8 records totaling $289. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $15,480 to $162,102. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $2,427,385 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,714,125 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,958,478 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,014,491 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,401,116 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,372,187 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,315,847 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,742,504 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,042,762 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,756,315 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,03512,019$2,427,385
20161,09813,270$2,714,125
201799813,926$2,958,478
201895413,627$3,014,491
20191,12715,766$3,401,116
202096315,068$3,372,187
202195114,404$3,315,847
202283216,204$2,742,504
202387655,710$3,042,762
202478256,817$2,756,315

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$87K$173K2015 Drug cost: $15,480 (USD; Tot_Drug_Cst)2016 Drug cost: $35,921 (USD; Tot_Drug_Cst)2017 Drug cost: $69,303 (USD; Tot_Drug_Cst)2018 Drug cost: $81,762 (USD; Tot_Drug_Cst)2019 Drug cost: $91,367 (USD; Tot_Drug_Cst)2020 Drug cost: $97,049 (USD; Tot_Drug_Cst)2021 Drug cost: $72,363 (USD; Tot_Drug_Cst)2022 Drug cost: $77,952 (USD; Tot_Drug_Cst)2023 Drug cost: $173,205 (USD; Tot_Drug_Cst)2024 Drug cost: $162,102 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015113235$15,480
2016144339$35,921
2017151373$69,303
2018106261$81,762
2019121311$91,367
2020125350$97,049
2021144433$72,363
2022106337$77,952
2023126408$173,205
2024138450$162,102

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system237243$88
67028Injection of drug into eye3631,645$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5191,122$65
92134Imaging of retina6211,944$29
92250Photography of the retina227256$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VabysmoFaricimab-Svoa371,060$112,786
EyleaAflibercept11308$21,925
Prednisolone AcetatePrednisolone Acetate572,713$2,475
Bromfenac SodiumBromfenac Sodium18485$1,882
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat705,037$1,216

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$289Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lawrence Y. Ho, M.D.?

Tedicare shows public-source Medicare data for Lawrence Y. Ho, M.D. (NPI 1609078427), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lawrence Y. Ho, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lawrence Y. Ho, M.D.?

Lawrence Y. Ho, M.D. is linked to PENNSYLVANIA RETINA SPECIALISTS PC (billing NPI 1568428126) in the available physician profile data.

Does Lawrence Y. Ho, M.D. have Open Payments data?

Lawrence Y. Ho, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.